Ready, Set, Glow! Segway-Ninebot Rolls Out New C2 Lite eKickScooter for KidsReady, Set, Glow! Segway-Ninebot Rolls Out New C2 Lite eKickScooter for Kids PR Newswire
||
SYDNEY, Oct. 16, 2024 /PRNewswire/ — Get ready to zip, zoom, and light up the streets with the all-new Segway-Ninebot C2 Lite. Segway-Ninebot, one of the world’s leading manufacturers... 
Cognizant Announces Multi-Agent Orchestration for its Neuro® AI PlatformCognizant Announces Multi-Agent Orchestration for its Neuro® AI Platform PR Newswire
||
Enhanced platform integrates powerful multi-agent AI orchestration that can accelerate the enterprise AI productivity-to-growth journey Dozens of businesses have already leveraged the platform to rapidly identify, build and pilot... 
Tiong Seng Opens First Senior-Care Facility in Tianjin to Tap on China’s Growing Silver EconomyTiong Seng Opens First Senior-Care Facility in Tianjin to Tap on China’s Growing Silver Economy Media OutReach Newswire
||
Tiong Seng Silvercare launches first Watermark Lifestyle Centre in Tianjin, focusing on elderly care services as part of China’s growing Silver Economy The centre aligns with Singapore’s Active Ageing... 
Newway Launches New Indoor Environmental Quality (IEQ) LaboratoryNewway Launches New Indoor Environmental Quality (IEQ) Laboratory Media OutReach Newswire
||
SINGAPORE – Media OutReach Newswire – 16 October 2024 – Homegrown air conditioning specialists, Newway SG, demonstrates a strong commitment to managing the impacts of indoor air quality (IAQ)... 
HUTCHMED Announces that TAGRISSO® plus ORPATHYS® demonstrated high, clinically meaningful response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trialHUTCHMED Announces that TAGRISSO® plus ORPATHYS® demonstrated high, clinically meaningful response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial GlobeNewswire
||
– New data demonstrate efficacy for the oral treatment combination to address MET-driven resistance in EGFR-mutated lung cancer – – MET is a common biomarker in this setting for patients who develop... 
Palace backs reopening of probe on Duterte’s drug war killingsPalace backs reopening of probe on Duterte’s drug war killings Catherine S. Valente
||
MANILA, Philippines — Malacañang on Wednesday said it supported the plan of the Philippine National Police (PNP) to reinvestigate the high-profile killings related to the war on illegal drugs... 
Olivier Falut appointed EUROAPI’s Chief Financial OfficerOlivier Falut appointed EUROAPI’s Chief Financial Officer GlobeNewswire
||
Press Release Paris – October 16, 2024 – Olivier Falut has been appointed EUROAPI’s Chief Financial Officer, effective October 17, 2024, and will be a member of... 
Bioversys Announces Last Patient Last Visit in BV100 Phase 2 Clinical Trial in Ventilator Associated Bacterial Pneumonia (VABP) and Provides a Business UpdateBioversys Announces Last Patient Last Visit in BV100 Phase 2 Clinical Trial in Ventilator Associated Bacterial Pneumonia (VABP) and Provides a Business Update GlobeNewswire
||
BV100 Phase 2 preliminary results suggest BV100 is generally safe and well tolerated and showed strong initial signs of efficacy in VABP patientsStrategic investment from GIBF and launch of... 
UXLINK Celebrates Milestone of 28 Million Global Users, Reinforcing Its Status as the Largest Web3 Social PlatformUXLINK Celebrates Milestone of 28 Million Global Users, Reinforcing Its Status as the Largest Web3 Social Platform GlobeNewswire
||
SINGAPORE, Oct. 16, 2024 (GLOBE NEWSWIRE) — UXLINK, the world’s largest Web3 social platform and infrastructure provider, proudly announces a significant milestone of reaching over 28 million users globally.... 
New data on aprocitentan to be presented at the ASN Kidney Week 2024New data on aprocitentan to be presented at the ASN Kidney Week 2024 GlobeNewswire
||
Allschwil, Switzerland – October 16, 2024 Idorsia Ltd (SIX: IDIA) today announced that new data on aprocitentan, Idorsia’s endothelin receptor antagonist, will be presented at the American Society of...